Rhodus et al. in 2005 (15) reported increased concentrations of salivary IL-6 and TNF-α in oral cancer patients and in patients with oral precancerous lesions, while St John et al. (17) found no significant differences in salivary IL-6 in oral cancer patients compared to healthy controls. This evidence concerns the gene TNF and lip and oral cavity carcinoma.